SEC Filing Summary

Christopher R. Reidy, a director at Encompass Health Corp, acquired 21 shares of common stock on July 15, 2026, through a dividend reinvestment program. The shares were awarded as restricted stock units (RSUs) due to a dividend payment of $0.19 per share, with the closing stock price at $109.88. This transaction is part of a plan where RSUs are credited to non-employee directors' accounts in connection with dividend payments. Additionally, on July 16, 2026, Reidy acquired 319 shares of Encompass Health Common Stock for $112.40 per share, totaling 17777 shares post-transaction. These shares were purchased through the Directors Deferred Stock Investment Plan, which allows directors to defer a percentage of their fees to purchase company stock, with reinvested dividends. Both transactions are reported on Form 4.